selinexor
BTK Inhibitors, Other Blood Cancer Drugs Are Being Tapped for COVID-19
Studies are underway exploring immunomodulating agents approved for hematologic malignancies in the treatment of ...
JULY 23, 2020
Xpovio Approved to Treat Relapsed or Refractory DLBCL
The FDA granted accelerated approval to selinexor (Xpovio, Karyopharm) for the treatment of adult patients with ...
JUNE 23, 2020
FDA Advisory Committee Rejects Selinexor for MM, Wants More Data
The ODAC voted 8 to 5 recommending that the FDA wait for the results from the randomized, open-label, phase 3 ...
FEBRUARY 28, 2019
Load more